Moderna’s stock rallies as settlement of a patent dispute clears vaccine pipeline

The deal would provide ‘certainty’ for Moderna’s vaccine portfolio.

Previous Article

Oil-production shutdowns loom as some Middle Eastern countries could run out of storage

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *

− 2 = 1
Powered by MathCaptcha

Subscribe to our Newsletter

Subscribe to our email newsletter to get the latest posts delivered right to your email.
Pure inspiration, zero spam ✨